Gene · 7518
Papers3,098
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,098
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Modeling of DNA Damage Repair and Cell Response in Relation to p53 System Exposed to Ionizing Radiation. | Int J Mol Sci | 2022 | 36232625 | PubTator, text mining | PubMed |
| Molecular Mechanisms Driving the Formation of Brain Metastases. | Cancers (Basel) | 2022 | 36230886 | PubTator, text mining | PubMed |
| Targeting the DNA Damage Response and DNA Repair Pathways to Enhance Radiosensitivity in Colorectal Cancer. | Cancers (Basel) | 2022 | 36230796 | PubTator, text mining | PubMed |
| DNA damage response revisited: the p53 family and its regulators provide endless cancer therapy opportunities. | Exp Mol Med | 2022 | 36207426 | PubTator, text mining | PubMed |
| Role of K63-linked ubiquitination in cancer. | Cell Death Discov | 2022 | 36202787 | PubTator, text mining | PubMed |
Efficacy of neoadjuvant docetaxel + cisplatin chemo-hormonal therapy versus docetaxel chemo-hormonal therapy in patients with locally advanced prostate cancer with germline DNA damage repair gene alterations. | Ther Adv Med Oncol | 2022 | 36199621 | PubTator, text mining | PubMed |
| HCV and tumor-initiating stem-like cells. | Front Physiol | 2022 | 36187761 | PubTator, text mining | PubMed |
| Exploiting dietary fibre and the gut microbiota in pelvic radiotherapy patients. | Br J Cancer | 2022 | 36175620 | PubTator, text mining | PubMed |
| DNA repair pathways as a novel therapeutic strategy in esophageal cancer: A review study. | Cancer Rep (Hoboken) | 2022 | 36147024 | PubTator, text mining | PubMed |
| Integration of TE Induces Cancer Specific Alternative Splicing Events. | Int J Mol Sci | 2022 | 36142830 | PubTator, text mining | PubMed |
| Targeting the Heterogeneous Genomic Landscape in Triple-Negative Breast Cancer through Inhibitors of the Transcriptional Machinery. | Cancers (Basel) | 2022 | 36139513 | PubTator, text mining | PubMed |
| Small Extracellular Vesicles and Their Involvement in Cancer Resistance: An Up-to-Date Review. | Cells | 2022 | 36139487 | PubTator, text mining | PubMed |
| Precise exogenous insertion and sequence replacements in poplar by simultaneous HDR overexpression and NHEJ suppression using CRISPR-Cas9. | Hortic Res | 2022 | 36133672 | PubTator, text mining | PubMed |
| Modulating glioblastoma chemotherapy response: Evaluating long non-coding RNA effects on DNA damage response, glioma stem cell function, and hypoxic processes. | Neurooncol Adv | 2022 | 36105389 | PubTator, text mining | PubMed |
| FBXW7 inactivation induces cellular senescence via accumulation of p53. | Cell Death Dis | 2022 | 36104351 | PubTator, text mining | PubMed |
| Overcoming the Impact of Hypoxia in Driving Radiotherapy Resistance in Head and Neck Squamous Cell Carcinoma. | Cancers (Basel) | 2022 | 36077667 | PubTator, text mining | PubMed |
| Multi-pathway DNA-repair reporters reveal competition between end-joining, single-strand annealing and homologous recombination at Cas9-induced DNA double-strand breaks. | Nat Commun | 2022 | 36075911 | PubTator, text mining | PubMed |
| Vanguard is a Glucose Deprivation-Responsive Long Non-Coding RNA Essential for Chromatin Remodeling-Reliant DNA Repair. | Adv Sci (Weinh) | 2022 | 36047643 | PubTator, text mining | PubMed |
| Topoisomerase 2β and DNA topology during B cell development. | Front Immunol | 2022 | 36045673 | PubTator, text mining | PubMed |
| Activation of recombinational repair in Ewing sarcoma cells carrying EWS-FLI1 fusion gene by chromosome translocation. | Sci Rep | 2022 | 36042341 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7518/papers?page=20